Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Scientists at Stanford University School of Medicine have developed a method for stem cell transplants that may do away with the need for prior systematic treatment with chemotherapy or...

Though approved therapies for multiple sclerosis (MS) exist, the condition remains incurable leading to greater interest...

A large study of multiple sclerosis patients has concluded clinical and brain imaging assessments drawn from magnetic resonance imaging (MRI) scans are poor measures of long-term prognosis for...

New research from the University of Dundee, and funded by Arthritis Research UK and the MRC, has shown that targeting a specific group of enzymes could be a viable strategy for treating autoimmune...

A new study, published in Neurology, has pointed to a possible benefit to patients of commencing MS treatment as soon as possible after...

Patients with aggressive onset multiple sclerosis (AOMS), characterised by a rapidly progressing disease course and accumulation of disability, may benefit from early aggressive therapies instead...

Transcutaneous electrical nerve stimulation (TENS) might be an option to treat spasticity, one of...

A protein activated by vitamin D could be involved in repairing damage to myelin in people with multiple sclerosis (MS), according to new research from the University of Cambridge.

The...

Women with multiple sclerosis and people diagnosed with the condition at a younger age are more likely to have a benign course of
MS, remaining fully functional for decades, according to...

Researchers have developed an antibody with potential therapeutic effects that could help in the treatment of multiple sclerosis.

Inserm Unit U919, directed by Prof. Denis Vivien ("Serine...

Pages

Live Chat Software by Click4Assistance UK